← Open Payments lookup

STEFANIE GUNN: Open Payments

NPI 1114166501 · IRMO, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,641 in 152 payments from 23 companies in 2025. Trend: 2023 $2,045 · 2024 $3,657 · 2025 $2,641

Food & beverage: $2,641
CompanyPaymentsAmount
Organogenesis Inc.4$332
ABBVIE INC.24$252
Novo Nordisk Inc13$235
Otsuka America Pharmaceutical, Inc.11$232
Amgen Inc.19$207
AstraZeneca Pharmaceuticals LP9$186
Corcept Therapeutics11$172
Salix Pharmaceuticals, a division of Bausch Health US, LLC17$165
Bayer Healthcare Pharmaceuticals Inc.7$152
Abbott Laboratories8$120

Products named: REXULTI, Korlym, XIFAXAN, Kerendia, OTEZLA, Wegovy, NOVACHOR, AIRSUPRA.

Industry payments across SC — which companies pay providers there.